ABHD6 and thanatophoric dysplasia: In addition, ABHD6—an enzyme that hydrolyzes 2-AG to AA—was upregulated in the blood of TD patients aged 13–16, and ABHD6 expression was positively correlated with symptom severity in adult TD patients [66,67].